Back to User profile » Dr Mostafa M Bahaa

Papers published by Dr Mostafa M Bahaa:


Immunomodulatory and Anti-Inflammatory Effects of Ketotifen Versus Vitamin E in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Pilot Study

Aldossary KM, Talkhan H, Abdulelah FM, Kotkata FA, Elmorsi YM, Habba E, Eltantawy N, Mourad SA, Hamza E, Sami HM, Ali KABK, Elberri EI, Bahaa MM

Drug Design, Development and Therapy 2026, 20:593561

Published Date: 21 April 2026

Efficacy of Paroxetine as an Adjuvant Therapy in Rheumatoid Arthritis Patients: A Randomized Controlled Study

Aldossary KM, Abdallah MS, Mosalam EM, Kamal N, Saif DS, Elsayed SAR, Afifi N, Zakaraia HG, Khrieba MO, Bahaa MM

Drug Design, Development and Therapy 2025, 19:11925-11939

Published Date: 30 December 2025

A Randomized Controlled Pilot Study Evaluating the Safety and Efficacy of Nifuroxazide in Patients with Ulcerative Colitis

AlRasheed HA, Abdallah MS, El-Khateeb E, Kamal M, Alrubia S, Alsegiani AS, Ahmed TI, Bahaa MM

Drug Design, Development and Therapy 2025, 19:5539-5552

Published Date: 30 June 2025

Fenofibrate as an Adjunct Therapy for Ulcerative Colitis: Targeting Inflammation via SIRT1, NLRP3, and AMPK Pathways: A Randomized Controlled Pilot Study

Graphical Abstract of Fenofibrate as an Adjunct Therapy for Ulcerative Colitis: Targeting Inflammation via SIRT1, NLRP3, and AMPK Pathways: A Randomized Controlled Pilot Study

Alarfaj SJ, Bahaa MM, Elmasry TA, Elberri EI, El-Khateeb E, Hamouda AO, Salahuddin MM, Kamal M, Gadallah ANAA, Eltantawy N, Yasser M, Negm WA, Hamouda MA, Alsegiani AS, Alrubia S, Eldesoqui M, Abdallah MS

Drug Design, Development and Therapy 2024, 18:5239-5253

Published Date: 16 November 2024

COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach

Abd El Hadi SR, Zien El-Deen EE, Bahaa MM, Sadakah AA, Yassin HA

Drug Design, Development and Therapy 2021, 15:3313-3330

Published Date: 30 July 2021